GLP-1 Digest
Subscribe
Sign in
Home
Podcast
Archive
Leaderboard
About
How to Compete as a New Entrant in the DTC Obesity Market
Ep. 10 with Barclay’s Emily Field: What will patients pay a premium for?
Oct 8
•
Ashwin Sharma, MD
7
1
Latest
Top
Discussions
🎧 How Shotsy Grew to 350,000 Monthly Active GLP-1 Users, Ep. 9 with Aja Beckett
A conversation the founder of one the fastest-growing GLP-1 companion apps
Aug 2
•
Ashwin Sharma, MD
6
2
🎧 Can AI Stop GLP-1 Patients From Churning? Ep.8 with Dr. Paul Sacher
How DTC platforms are keeping customers without lowering prices
Jul 8
•
Ashwin Sharma, MD
7
3
🎧 Genetics Could Decide Who Wins the GLP-1 Market, Ep. 7 with 23andMe’s Dr. Adam Auton
Predicting weight loss and side effects before treatment begins
Jun 14
•
Ashwin Sharma, MD
5
1
53:20
🎧 Can Peptides Become a Real DTC Business? Ep.6 with Tim Gutwald
Before they become a real revenue stream, founders need to solve three unsexy problems
May 17
•
Ashwin Sharma, MD
3
2
58:47
🎧 GLP-1s Are Coming for the Snack Aisle, Ep. 5 with Henry Dimbleby
On shrinking food volumes, and why consumers want more value per bite
May 3
•
Ashwin Sharma, MD
5
2
53:37
What happens when GLP-1s go off-patent?
Five charts that’ve caught my eye
Apr 26
•
Ashwin Sharma, MD
21
3
5
🎧 Can GLP-1s Save the NHS? Ep. 4 with Lord James Bethell
Healthspan is decreasing in the UK, and the private market could help turn things around
Apr 12
•
Ashwin Sharma, MD
10
2
41:12
See all
GLP-1 Digest
The GLP-1 newsletter for founders, operators and investors.
Subscribe
Recommendations
View all 6
The Argument
The Argument
The Device Files: From Concept to Commercialization
Blythe Karow
Breakthrough
Samuel Hume
In-Network
David Ohta
The Gut Group
Dr Arif Hussenbux MBBS
GLP-1 Digest
Subscribe
About
Archive
Recommendations
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts